Valuation : TransMedics Group, Inc.

Market Cap 3B 2.58B 2.43B 2.21B 4.14B 285B 4.15B 28.77B 11.12B 145B 11.25B 11.01B 460B P/E 2026 *
62x
P/E 2027 * 39.3x
Enterprise Value 2.96B 2.54B 2.39B 2.18B 4.08B 281B 4.1B 28.38B 10.97B 143B 11.1B 10.86B 454B EV / Sales 2026 *
3.98x
EV / Sales 2027 * 3.26x
Free-Float
96.36%
Yield 2026 *
-
Yield 2027 * -
1 day-2.12%
1 week+2.50%
Current month+1.80%
1 month+2.99%
3 months+16.30%
6 months-35.89%
Current year-28.98%
1 week 83.61
Extreme 83.61
90.11
1 month 81.34
Extreme 81.3401
95.18
Current year 60.1
Extreme 60.105
151.85
1 year 60.1
Extreme 60.105
156
3 years 36.42
Extreme 36.4201
177.37
5 years 10
Extreme 10
177.37
10 years 10
Extreme 10
177.37
Manager TitleAgeSince
Chief Executive Officer 57 1998-07-31
Director of Finance/CFO 55 2024-12-01
Chief Operating Officer 43 2023-02-01
Director TitleAgeSince
Director/Board Member 57 1998-07-31
Chairman 81 2010-12-31
Director/Board Member 78 2016-01-31
Date Insider Type Main position Quantity % Market Cap. Importance
8/17/26 Don

Chairman

-18,000 0.0528%
7/10/26 Free

Chief Financial Officer

43,399 0.1273%
7/10/26 Free

Chief Operating Officer

29,511 0.0866%
Change 5-day change 1-year change 3-year change Capi.($)
-2.12%+2.50%-20.21%+47.52% 3B
+0.44%-0.47%+25.56%+16.87% 224B
-0.19%-2.41%+5.41%-17.52% 144B
+0.88%-5.01%-24.45%+18.45% 125B
-0.04%-7.05%-58.41%-16.54% 65.16B
+0.06%-1.95%-18.10%-13.39% 50.05B
-0.62%-5.11%+7.99%+16.35% 49.67B
-1.43%-4.39%+14.65%+26.98% 40.81B
+0.47%-1.79%+34.70%+53.59% 39.77B
-2.87%-3.87%+108.72%+29.45% 30.96B
Average -0.55%-1.96%+7.59%+16.18% 77.22B
Weighted average by Cap. +0.01%-2.27%+5.73%+8.95%

Financials

2026 *2027 *
Net sales 742M 638M 601M 548M 1.02B 70.58B 1.03B 7.12B 2.75B 35.96B 2.79B 2.72B 114B 875M 753M 709M 646M 1.21B 83.24B 1.21B 8.4B 3.25B 42.4B 3.28B 3.21B 134B
Net income 51.99M 44.74M 42.12M 38.38M 71.81M 4.95B 72.1M 499M 193M 2.52B 195M 191M 7.98B 89.08M 76.65M 72.18M 65.77M 123M 8.48B 124M 855M 331M 4.32B 335M 327M 13.68B
Net Debt -40.26M -34.64M -32.62M -29.72M -55.61M -3.83B -55.83M -387M -149M -1.95B -151M -148M -6.18B -146M -125M -118M -108M -201M -13.86B -202M -1.4B -541M -7.06B -547M -535M -22.37B
Logo TransMedics Group, Inc.
TransMedics Group, Inc. is a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart and liver failure. The Company specializes in portable extracorporeal warm perfusion and assessment of donor organs for transplantation. Its Organ Care System (OCS) is a portable organ perfusion, optimization and monitoring system that utilizes its customized technology to replicate near-physiologic conditions for donor organs outside the human body. It also developed its National OCS Program (NOP), which is a turnkey solution to provide outsourced organ procurement, OCS perfusion management and transplant logistics services, to provide transplant programs in the United States. Its logistics services include aviation transportation and other coordination activities. Its NOP provides trained organ procurement surgeons, clinical specialists and transplant coordinators that provide an end-to-end clinical solution using its OCS technology.
Employees
898
Date Price Change Volume
26-09-09 US$86.40 -2.12% 665,155
26-09-08 US$88.27 -1.90% 594,550
26-09-04 US$89.98 +3.45% 542,804
26-09-03 US$86.98 +3.19% 574,877
26-09-02 US$84.29 +2.49% 589,835
Trader
Investor
Global
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
12
Last Close Price
86.40USD
Average target price
97.30USD
Spread / Average Target
+12.62%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. TMDX Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!